HIV infection and tuberculosis

Kekkaku

Volumn 78, Issue 1, 2003, Pages 45-49

  Nagai, Hideaki ^a  

^a TOKYO NATIONAL HOSPITAL   (Japan)

Author keywords

Acquired immunodeficiency syndrome; Human immunodeficiency virus; Immune reconstitution syndrome; Protease inhibitor; Tuberculosis

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CYTOCHROME P450; CYTOKINE; EFAVIRENZ; ETHAMBUTOL; INDINAVIR; ISONIAZID; NELFINAVIR; NEVIRAPINE; PROTEINASE INHIBITOR; PYRAZINAMIDE; RIFABUTIN; RIFAMPICIN; RITONAVIR; SAQUINAVIR; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

B CELL LYMPHOMA; BACTERIAL INFECTION; CASEOUS NECROSIS; CELL MIGRATION; CONFERENCE PAPER; CYTOTOXIC T LYMPHOCYTE; DISEASE ASSOCIATION; DRUG CONTRAINDICATION; DRUG CROSS REACTIVITY; FEVER; FUTUROLOGY; GRANULOMA; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITAL CARE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; JAPAN; LIVER METABOLISM; LYMPH NODE; MACROPHAGE ACTIVATION; MILIARY TUBERCULOSIS; MORBIDITY; NATURAL KILLER CELL; PROTEINASE INHIBITION; TISSUE NECROSIS; TUBERCULIN TEST; TUBERCULOSIS; TUBERCULOUS MENINGITIS;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANTITUBERCULAR AGENTS; HIV INFECTIONS; HUMANS; RISK; TUBERCULOSIS;

EID: 0037242780     PISSN: 00229776     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (16)

1. Nakata K, Rom WN, Honda Y, et al.: Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication in the lung. Am J Respir Crit Care Med. 1997; 155: 996-1003.
2. Ellner JJ, Hinman AR, Dooley SW, et al.: Tuberculosis symposium: emerging problems and promise. J Infect Dis. 1993; 168: 537-551.
3. Centers for Disease Control and Prevention: Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: Principles of therapy and revised recommendations. MMWR. 1998; 47 (RR-20): 1-51.
4. Alwood K, Keruly JC, Morrore-Rice K, et al.: Effectiveness of supervised, intermittent therapy for tuberculosis in HIV-infected patients. AIDS. 1994; 8: 1103-1108.
5. Ungo JR, Jones D, Ashkin D, et al.: Antituberculosis drug-induced hepatotoxicity. The role of hepatitis C virus and the human immunodeficiency virus. Am J Respir Crit Care Med. 1998; 157: 1871-1876.
6. Centers for Disease Control and Prevention: Updated guidelines for the use of rifabutin or rifampin for the treatment and prevention of tuberculosis among HIV-infected patients taking protease inhibitors or nonnucleoside reverse transcriptase inhibitors. MMWR. 2000; 49: 185-189.
7. Narita M, Ashkin D, Hollender ES, et al.: Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. Am J Respir Crit Care Med. 1998; 158: 157-161.
8. Burman WJ, Jones BE: Treatment of HIV-related tuberculosis in the era of effective antiretroviral therapy. Am J Respir Crit Care Med. 2001; 164: 7-12.
9. Ackah AN, Coulibaly D, Digbeu H, et al.: Response to treatment, mortality, and CD4 lymphocyte counts in HIV-infected persons with tuberculosis in Abidjan, Côte d'Ivoire. Lancet. 1995; 345: 607-610.
10. Murray J, Sonnenberg P, Shearer SC, et al.: Human immunodeficiency virus and the outcome of treatment for new and recurrent pulmonary tuberculosis in African patients. Am J Respir Crit Care Med. 1999; 159: 733-740.
11. Navas E, Moreno L, Martin-Davila V, et al.: Tuberculosis reactivation in AIDS patients treated with highly active antiretroviral therapy [abstract]. 39th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco. 1999.
12. Dean GL, Edwards SG, Ives NJ, et al.: Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy. AIDS. 2002; 16: 75-83.
13. Narita M, Stambaugh JJ, Hollender ES, et al.: Use of rifabutin with protease inhibitors for human immunodeficiency virus-infected patients with tuberculosis. Clin Infect Dis. 2000; 30: 779-783.
14. Centers for Disease Control and Prevention: Update: Fatal and Severe Liver Injuries Associated with Rifampin and Pyrazinamide for Latent Tuberculosis Infection, and Revisions in American Thoracic Society/CDC Recommendations - United States, 2001. MMWR. 2001; 50: 733-735.